Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules: A Multicenter Study

Thyroid ◽  
2015 ◽  
Vol 25 (1) ◽  
pp. 112-117 ◽  
Author(s):  
Jin Yong Sung ◽  
Jung Hwan Baek ◽  
So Lyung Jung ◽  
Ji-hoon Kim ◽  
Kyu Sun Kim ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Multicenter Study ◽  
Thyroid Nodules ◽  
Autonomously Functioning Thyroid Nodules

Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules

2009 ◽  
Vol 33 (9) ◽  
pp. 1971-1977 ◽  
Author(s):  
Jung Hwan Baek ◽  
Won-Jin Moon ◽  
Yoon Suk Kim ◽  
Jeong Hyun Lee ◽  
Ducky Lee
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Autonomously Functioning Thyroid Nodules

12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules

Endocrine ◽  
2016 ◽  
Vol 57 (3) ◽  
pp. 402-408 ◽  
Author(s):  
Stella Bernardi ◽  
Fulvio Stacul ◽  
Andrea Michelli ◽  
Fabiola Giudici ◽  
Giulia Zuolo ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Autonomously Functioning Thyroid Nodules

scholarly journals Ultrasound-guided radiofrequency ablation (RFA) of benign symptomatic thyroid nodules – initial UK experience

2019 ◽  
pp. 20190026
Author(s):  
Susan Jawad ◽  
Simon Morley ◽  
Sofia Otero ◽  
Timothy Beale ◽  
Steven Bandula
Keyword(s):  
Radiofrequency Ablation ◽  
Thyroid Nodules ◽  
Post Treatment ◽  
Published Data ◽  
Thyroid Function Tests ◽  
Related Quality ◽  
Autonomously Functioning Thyroid Nodules ◽  
Nodule Volume ◽  
Pre Treatment

Objective: To report on the use of RFA for the treatment of symptomatic benign and autonomously functioning thyroid nodules (AFTNs) in the first reported UK cohort. Methods: Patients treated over a 19-month period were retrospectively reviewed. Nodules were assessed pre-treatment and at 1 and 6 months post-treatment. Nodule volume was calculated and cosmetic assessment and thyroid-related quality of life (QoL) scores were recorded at each time point. Thyroid function tests (TFTs) were recorded at all three time points for patients with ATFNs. Results: 46 patients with 50 nodules were treated with no complications. The mean volume reduction 1-month post-treatment was 53 +- 14.9 % ( p < 0.0001). Six month data was available for 31 nodules and showed a mean 67 +- 17.6% vol reduction ( p < 0.0001). Five of the six patients with ATFNs were euthyroid at 1-month post-procedure. 6-month data was available on three of these patients, and all remained euthyroid. The thyroid-related QoL and cosmetic scores also improved. Data from 23 patients was available pre-treatment and at 6 months post-treatment and there was a significant ( p < 0.0001) reduction in QoL score. Pre-treatment, 82 % of nodules were readily visible at rest, decreasing to 12.5 % 6 months after treatment ( p < 0.0001). Conclusions: Results align with published data suggesting that RFA is effective at reducing nodule volume and at treating ATFNs and leads to improvement in thyroid-related QoL and cosmetic scores. Advances in knowledge: This early UK experience demonstrates that day-case radiofrequency ablation can provide safe and effective treatment of benign symptomatic thyroid nodules.

scholarly journals Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now

2021 ◽  
Vol 12 ◽  
Author(s):  
Ralph P. Tufano ◽  
Pia Pace-Asciak ◽  
Jonathon O. Russell ◽  
Carlos Suárez ◽  
Gregory W. Randolph ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Radiofrequency Ablation ◽  
Minimally Invasive ◽  
Thyroid Nodules ◽  
Standard Of Care ◽  
Low Risk ◽  
Autonomously Functioning Thyroid Nodules ◽  
Ablative Techniques ◽  
The Right ◽  
Invasive Techniques

Thermal and chemical ablation are minimally invasive procedures that avoid removal of the thyroid gland and target symptomatic nodules directly. Internationally, Radiofrequency ablation (RFA) is among one of the most widely used thermal ablative techniques, and is gaining traction in North America. Surgery remains the standard of care for most thyroid cancer, and in the right clinical setting, Active Surveillance (AS) can be a reasonable option for low risk disease. Minimally invasive techniques have emerged as an alternative option for patients deemed high risk for surgery, or for those patients who wish to receive a more active treatment approach compared to AS. Herein, we review the literature on the safety and efficacy of RFA for treating benign non-functioning thyroid nodules, autonomously functioning thyroid nodules, primary small low risk thyroid cancer (namely papillary thyroid cancer) as well as recurrent thyroid cancer.

Sign in / Sign up

Export Citation Format

Share Document